Genomics-Microbiome Based Assessment of Bidirectional Causality Between Gut Microbiota and Psoriasis
Qian Gao,Jing-Hua Liu,Wen-Yi Ma,Zi-Lin Cheng,Ping-Sheng Hao,Na-Na Luo
DOI: https://doi.org/10.2147/ccid.s450227
2024-02-14
Clinical Cosmetic and Investigational Dermatology
Abstract:Qian Gao, 1, 2 Jing-Hua Liu, 1, 2 Wen-Yi Ma, 1, 2 Zi-Lin Cheng, 1, 2 Ping-Sheng Hao, 1 Na-Na Luo 1 1 Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China; 2 Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China Correspondence: Ping-Sheng Hao; Na-Na Luo, Email ; Background: Traditional observational studies have found a possible risk association of the gut microbiota for psoriasis. Meanwhile, psoriasis may also affect the changes in the gut microbiota. However, the available evidence does not demonstrate a reciprocal relationship between the gut microbiota and psoriasis. This limits our understanding on the role of the gut microbiota in the mechanisms of psoriasis. Methods: To address this question we used Mendelian randomization, a novel epidemiological approach, and acquired the largest current gut microbiota GWAS data from the MiBioGen consortium as well as psoriasis GWAS data from the FinnGen consortium, and performed two-sample bidirectional MR analyses using a multiple MR analysis approach. Finally, the robustness of the results was assessed by sensitivity analysis. Results: Our results indicate that five bacterial genera are causally related to psoriasis and psoriasis is causally related to four bacterial genera. Conclusion: These results suggest a bidirectional causal influence of psoriasis on the gut microbiota. Our results somewhat challenge the causal inferences of previous observational studies. We found that the specific bacterial genera with a risk effect on psoriasis were different from those found to characterize psoriasis in previous observational studies, and that these psoriasis-characterizing genera were inversely associated with psoriasis. Keywords: Mendelian randomization, psoriasis, causal relationship, gut microbiota, bidirectional Mendelian randomization analysis Psoriasis is a chronic and complex skin disease with systemic multisystem comorbidities that occurs in approximately 2.4% of the world's population 1. Current treatments for psoriasis have limited effectiveness and are prone to relapse after discontinuation of medication, which seriously affects the patient's survival rate and quality of life. Recently, WHO has proposed psoriasis as a major global health problem. 2 Psoriasis pathogenesis mainly involves immunity, genetic susceptibility, and environmental factors. 3 Among them, the role of intestinal microbiota in psoriasis pathogenesis has received increasing attention. Many studies have shown that changes in the intestinal microbiota may play a non-negligible role in psoriasis. For example, epidemiologic investigations have found an increased risk of psoriasis in inflammatory bowel disease, obesity, 4 and other conditions accompanied by intestinal dysbiosis. There are also several observational studies that have shown by macro-genetic sequencing of fecal samples that the composition of the intestinal flora is significantly different between psoriasis patients and healthy controls. 5 Not only that, but patients with psoriasis also have significant dysregulation of intestinal microbiota metabolites, such as fatty acid binding protein and tight junction protein-3. 6 In addition, probiotics significantly improved skin lesion severity in psoriasis-like mice. 7 This evidence suggests that the gut microbiota may be strongly associated with psoriasis, but it is not clear whether changes in gut flora trigger psoriasis or whether psoriasis causes changes in gut flora. In addition, it should not be overlooked that observational studies are susceptible to confounding factors leading to abnormally skewed results, such as metabolic disorders, cardiovascular disease, and obesity (as a psoriasis comorbidity), as well as age, dietary variations, and antibiotic use are all independent factors affecting the gut microbiota 8–10. The findings of the above observational studies limit the ability to make causal inferences about the gut microbiota and psoriasis. Therefore high-quality studies are necessary to determine the direct causal effect of gut microbiota and psoriasis. Mendelian randomization (MR) is a latest epidemiological research method that is based on Mendelian laws of inheritance and uses genetic variation as an instrumental variable for causal inference. Unlike traditional randomized controlled trials (RCTs), MR analyses are not influenced by human factors and can minimize bias anomalies caused by confounding factors. 11,12 Current large-scale genome-wide association studies (GWAS) provide extensive statistical -Abstract Truncated-
dermatology